Intermittent saline flushes during haemodialysis do not alleviate coagulation and clot formation in stable patients receiving reduced doses of dalteparin

Nephrology Dialysis Transplantation

Volumn 21, Issue 2, 2006, Pages 444-449

  Sagedal, Solbjørg ^a   Hartmann, Anders ^a   Osnes, Kåre ^a   Bjørnsen, Stine ^b   Torremocha, Josephine ^a   Fauchald, Per ^a   Kofstad, Johan ^a   Brosstad, Frank ^b  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

Anticoagulation; Clotting; Dalteparin; Haemodialysis; Prothrombin fragment 1+2; Saline flushes

Indexed keywords

ACETYLSALICYLIC ACID; BETA THROMBOGLOBULIN; BLOOD CLOTTING FACTOR 10A INHIBITOR; DALTEPARIN; HEMOGLOBIN; POLYSULFONE; SODIUM CHLORIDE; THROMBOCYTE FACTOR 1; THROMBOCYTE FACTOR 2; WARFARIN;

ADULT; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING PARAMETERS; BOLUS INJECTION; CONTROLLED STUDY; DIALYSIS MEMBRANE; DISEASE ACTIVITY; DISSEMINATED INTRAVASCULAR CLOTTING; DRUG DOSE REDUCTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; FIBRIN CLOT; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MEMBRANE FILTER; MULTIPLE LINEAR REGRESSION ANALYSIS; PRIORITY JOURNAL; RATING SCALE; REBOUND;

ADULT; AGED; AGED, 80 AND OVER; ANTICOAGULANTS; BLOOD COAGULATION; DALTEPARIN; FEMALE; HUMANS; MALE; MIDDLE AGED; RENAL DIALYSIS; SODIUM CHLORIDE;

EID: 31544469210     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfi203     Document Type: Article

References (27)

1. Hampers CL, Balufox MD, Merrill JP. Anticoagulation rebound after hemodialysis. N Engl J Med 1966; 275: 776-778
2. Swartz RD, Port FK. Preventing hemorrhage in high-risk hemodialysis: regional versus low-dose heparin. Kidney Int 1979; 16: 513-518
3. Swartz RD. Hemorrhage during high-risk hemodialysis using controlled heparinization. Nephron 1981; 28: 65-69
4. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med 1983; 308: 258-261
5. Hofbauer R, Moser D, Frass M et al. Effect of anticoagulation on blood membrane interactions during hemodialysis. Kidney Int 1999; 56: 1578-1583
6. Kelleher SP, Schulman G. Severe metabolic alkalosis complicating regional citrate hemodialysis. Am J Kidney Dis 1987; 9: 235-236
7. Meier-Kricsche HU, Finkel KW, Gitomer JJ, DuBose TD Jr. Unexpected severe hypocalcemia during continuous venovenous hemodialysis with regional citrate anticoagulation. Am J Kidney Dis 1999; 33: E8
8. Zusman RM, Rubin RH, Cato AE et al. Hemodialysis using prostacyclin instead of heparin as the sole antithrombotic agent. N Engl J Med 1981; 304: 934-939
9. Schwab SJ, Onorato JJ, Sharar LR, Dennis PA. Hemodialysis without anticoagulation. One-year prospective trial in hospitalized patients at risk for bleeding. Am J Med 1987; 83: 405-410
10. Sagedal S, Hartmann A, Sundstrom K, Bjornsen S, Brosstad F. Anticoagulation intensity sufficient for haemodialysis does not prevent activation of coagulation and platelets. Nephrol Dial Transplant 2001; 16: 987-993
11. Sagedal S, Hartmann A, Sundstrom K et al. A single dose of dalteparin effectively prevents clotting during haemodialysis. Nephrol Dial Transplant 1999; 14: 1943-1947
12. Altman DG. Practical Statistics for Medical Research. Chapman & Hall, London, Weinheim, New York, Tokyo, Melbourne, Madras, 1991; 1-588
13. Bratt G, Tornebohm E, Widlund L, Lockner D. Low molecular weight heparin (KABI 2165, Fragmin): Pharmacokinetics after intravenous and subcutaneous administration in human volunteers. Thromb Res 1986; 42: 613-620
14. Kandrotas RJ. Heparin pharmacokinetics and pharmacodynamics. Clin Pharmacokinet 1992; 22: 359-374
15. Caruana RJ, Raja RM, Bush JV, Kramer MS, Goldstein SJ. Heparin free dialysis: Comparative data and results in high risk patients. Kidney Int 1987; 31: 1351-1355
16. Ivanovich P, Xu CG, Kwaan HC, Hathiwala S. Studies of coagulation and platelet functions in heparin-free hemodialysis. Nephron 1983; 33: 116-120
17. Keller F, Seemann J, Preuschof L, Offermann G. Risk factors of system clotting in heparin-free haemodialysis. Nephrol Dial Transplant 1990; 5: 802-807
18. Sanders PW, Taylor H, Curtis JJ. Hemodialysis without anticoagulation. Am J Kidney Dis 1985; 5: 32-35
19. Casati S, Moia M, Graziani G et al. Hemodialysis without anticoagulants: efficiency and hemostatic aspects. Clin Nephrol 1984; 21: 102-105
20. Agresti J, Conroy JD, Olshan A et al. Heparin-free hemodialysis with Cuprophan hollow fiber dialyzers by a requent saline flush, high blood flow technique. Trans Am Soc Artif Intern Organs 1985; 31: 590-594
21. Romao JE Jr, Fadil MA, Sabbaga E, Marcondes M. Haemodialysis without anticoagulant: Haemostasis parameters, fibrinogen kinetic, and dialysis efficiency. Nephrol Dial Transplant 1997; 12: 106-110
22. Ruttmann TG, James MF, Viljoen JF. Haemodilution induces a hypercoagulable state. Br J Anaesth 1996; 76: 412-414
23. Ng KF, Lam CC, Chan LC. In vivo effect of haemodilution with saline on coagulation: A randomized controlled trial. Br J Anaesth 2002; 88: 475-480
24. Ruttmann TG, James MF, Aronson I. In vivo investigation into the effects of haemodilution with hydroxyethyl starch (200/0.5) and normal saline on coagulation. Br J Anaesth 1998; 80: 612-616
25. Grooteman MP, Nube MJ. Haemodialysis-related bioincompatibility: fundamental aspects and clinical relevance. Neth J Med 1998; 52: 169-178
26. Ambuhl PM, Wuthrich RP, Korte W, Schmid L, Krapf R. Plasma hypercoagulability in haemodialysis patients: Impact of dialysis and anticoagulation. Nephrol Dial Transplant 1997; 12: 2355-2364
27. Sagripanti A, Cupisti A, Baicchi U et al. Plasma parameters of the prothrombotic state in chronic uremia. Nephron 1993; 63: 273-278